Amine metabolism: A novel path to coronary artery vasospasm

Toxicology and Applied Pharmacology

Volumn 175, Issue 2, 2001, Pages 149-159

  Conklin, D J ^a   Boyce, C L ^a   Trent, M B ^b   Boor, P J ^b  

^a UNIVERSITY OF WISCONSIN EAU CLAIRE   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Allylamine (3 aminopropene); Amine oxidase EC 1.4.3.6; Aorta; Contraction; Human coronary artery disease; Hypercontractility; Myocardial necrosis; Semicarbazide sensitive amine oxidase; Tension oscillations; Vascular toxicity; Vasomotion; Vasospasm

Indexed keywords

ALLYLAMINE; MONOAMINE OXIDASE INHIBITOR; SEMICARBAZIDE;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY SPASM; ENZYME ACTIVITY; HEART INFARCTION; HUMAN; MALE; NONHUMAN; PATHOPHYSIOLOGY; RAT;

MAMMALIA;

EID: 0035449023     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.2001.9238     Document Type: Article

References (48)

1. Physiological and pathological implications of semicarbazide-sensitive amine oxidase (SSAO) also known as vascular adhesion molecule (VAP-1)
2. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycoaldehyde, 2-hydroxypropanal, and acrolein
3. Semicarbazide protection from in vivo oxidant injury of vascular tissue by allylamine
4. Ca channel activity
5. A critical review of the literature on acrolein toxicity
6. Effects of acetaldehyde, propionaldehyde, formaldehyde and acrolein on contractility, 14C-norepinephrine and 45calcium binding in isolated smooth muscle
7. Acrolein-induced smooth muscle hyperresponsiveness and eicosanoid release in excised ferret tracheae
8. Hydrogen peroxide effects on the contractile force and coronary flow of the rat isolated heart
9. Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin
10. Plasma semicarbazide-sensitive amine oxidase activity is elevated in patients with congestive heart failure
11. Allylamine cardiovascular toxicity: V. Tissue distribution and toxicokinetics after oral administration
12. Allylamine cardiotoxicity: III. Protection by semicarbazide and in vivo derangements of monoamine oxidase
13. Allylamine cardiovascular toxicity: A review
14. Allylamine cardiotoxicity: I. Sequence of pathologic events
15. In vivo metabolism of the cardiovascular toxin, allylamine
16. A role for a new vascular enzyme in the metabolism of xenobiotic amines
17. Methylamine metabolism to formaldehyde by a vascular enzyme
18. Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation
19. Semicarbazide-sensitive amine oxidase (SSAO) from human and bovine cerebrovascular tissues: Biochemical and immunohistological characterization
20. Eicosanoid-dependent and endothelium-independent oscillations of rat aorta
21. Allylamine cardiovascular toxicity: Evidence for aberrant vasoreactivity
22. Serum and cellular semicarbazide-sensitive amine oxidase in amine metabolism and cardiovascular toxicity
23. Dose-dependent sympathomimetic and cardioinhibitory effects of acrolein and formaldehyde in the anesthetized rat
24. Impaired endothelial vasodilator function in human coronary arteries
25. Vascular endothelial dysfunction and the pathogenesis of atherosclerosis
26. 2+ sequestration as a determinant of chaos and mixed-mode dynamics in agonist-induced vasomotion
27. Deleterious effects of hydrogen peroxide on the function and ultrastructure of cardiac muscle and the coronary vasculature of perfused rat hearts
28. Role of benzylamine oxidase in the cytotoxicity of allylamine toward aortic smooth muscle cells
29. Inhibition of vasoactive amine induced contractions of vascular smooth muscle by hydrogen peroxide in rabbit aorta
30. Human vascular adhesion protein-1 in smooth muscle cells
31. Ethanol ingestion on allylamine-induced experimental subendocardial fibrosis
32. Enhancement of constrictor response of spastic coronary arteries to acetylcholine but not to phenylephrine in patients with coronary spastic angina
33. A benzylamine oxidase distinct from monoamine oxidase B - Widespread distribution in man and rat
34. Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidase: Biochemical, pharmacological and toxicological aspects
35. Aminoacetone metabolism by semicarbazide-sensitive amine oxidase in rat aorta
36. Endothelial vasodilator function is preserved at the spastic/inflammatory coronary lesions in pigs
37. -86 → C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm
38. The role of sarcoplasmic reticulum in endothelium-dependent and endothelium-independent rhythmic contractions in the rabbit mesenteric artery
39. Allylamine-induced vascular toxicity in vitro: Prevention by semicarbazide-sensitive amine oxidase inhibitors
40. Contractile responses elicited by hydrogen peroxide in aorta from normotensive and hypertensive rats. Endothelial modulation and mechanisms involved
41. Calcium signaling in airway smooth muscle cells is altered by in vitro exposure to the aldehyde acrolein
42. Effects of Bay K 8644 on the spontaneous electrical and mechanical activities of the rat portal vein
43. Allylamine and acrolein toxicity in perfused rat hearts
44. Comparative toxicity of allylamine and acrolein in cultured myocytes and fibroblasts from neonatal rat heart
45. Protein-bound acrolein: Potential markers for oxidative stress
46. Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: Evidence for adrenergically mediated alterations in coronary artery tone
47. Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Possible consequences for diabetes
48. Formaldehyde produced endogenously via deamination of methylamine. A potential risk factor for initiation of endothelial injury